Sepsis-induced Multiple Organ Dysfunction Syndrome clinical trials at UCSF

2 in progress, 0 open to eligible people

Showing trials for

  • GM-CSF for Reversal of Immunoparalysis in Pediatric Sepsis-induced MODS

    Sorry, not yet accepting patients

    The GRACE-2 study is a prospective, multi-center, double-blind, randomized controlled trial of the drug GM-CSF vs placebo in children with sepsis-induced multiple organ dysfunction syndrome (MODS) who have immunoparalysis with mild to moderate inflammation.

    Oakland, California and other locations

  • Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS

    Sorry, not yet accepting patients

    The TRIPS study is a prospective, multi-center, double-blind, adaptively randomized, placebo-controlled clinical trial of the drug anakinra for reversal of moderate to severe hyperinflammation in children with sepsis-induced multiple organ dysfunction syndrome (MODS).

    Oakland, California and other locations

Last updated: